文献速递消化系统肿瘤支持与姑息治疗

合并精神分裂症与胰腺癌患者入院时癌症分期、治疗、住院时长及30天院内死亡率的关联:日本一项回顾性配对队列研究

Association of comorbid schizophrenia with cancer stage at admission, treatments, length of stay, and 30-day in-hospital mortality in patients with pancreatic cancer: A retrospective matched-pair cohort study in Japan.
PubMed 文献 · Eur J Cancer · 2025-04-26

该研究基于日本诊断程序组合数据库开展回顾性配对队列研究,按性别、年龄组、入院年份和入院机构以最大1:4比例将合并精神分裂症的胰腺癌患者与无精神障碍患者配对,采用广义估计方程的多变量回归分析。调整患者背景、医疗机构和治疗年份后,合并精神分裂症患者入院时为IV期癌症的可能性显著更高、接受化疗的可能性更低、住院时间更长且30天院内死亡风险更高;接受癌症导向手术的可能性更低但未达统计学显著。

要点

  • 合并精神分裂症的胰腺癌患者入院时为IV期的可能性显著更高。
  • 合并精神分裂症患者接受化疗的可能性显著更低,接受癌症导向手术的可能性更低但未达统计学显著。
  • 合并精神分裂症患者住院时间更长且30天院内死亡风险显著更高。

核心结论

  • 合并精神分裂症的胰腺癌患者入院时更可能为晚期癌症、更少接受化疗、住院时间更长且30天院内死亡风险更高。
  • 合并精神分裂症患者接受癌症导向手术的可能性更低,但未达统计学显著。

研究设计与样本

  • 回顾性配对队列研究,使用日本诊断程序组合数据库数据。
  • 合并精神分裂症的胰腺癌患者与无精神障碍患者按性别、年龄组、入院年份和入院机构以最大1:4比例配对。
  • 每对配对作为聚类,采用广义估计方程进行多变量回归分析。

主要发现

  • 调整患者背景因素、医疗机构和治疗年份后,合并精神分裂症患者入院时为IV期癌症的可能性显著更高。
  • 调整后合并精神分裂症患者接受化疗的可能性显著更低。
  • 调整后合并精神分裂症患者住院时间更长且30天院内死亡风险更高。
  • 合并精神分裂症患者接受癌症导向手术的可能性更低,但未达统计学显著。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies have suggested an association between comorbid schizophrenia and various outcomes in patients with cancer, including cancer stage at admission, treatment, and in-hospital mortality. However, studies focusing specifically on patients with pancreatic cancer are limited. AIMS: This study aimed to elucidate the association between comorbid schizophrenia and cancer stage at admission, treatment, length of stay, and 30-day in-hospital mortality in patients with pancreatic cancer, while considering patient background factors, medical facilities, and year of treatment. METHOD: We conducted a retrospective matched-pair cohort study using data from the Japanese Diagnosis Procedure Combination database. Patients with pancreatic cancer and comorbid schizophrenia were matched to those without psychiatric disorders at a maximum ratio of 1:4 according to sex, age group, year of admission, and admission facility. Each matched pair was treated as a cluster, and multivariable regression analyses using generalised estimating equations were performed to evaluate the association between psychiatric comorbidities and cancer-related outcomes. RESULTS: After adjusting for patient background factors, medical facilities, and the year of treatment, patients with comorbid schizophrenia were significantly more likely to be admitted with stage IV cancer, less likely to undergo chemotherapy, and more likely to have longer hospital stays and higher 30-day in-hospital mortality than those without psychiatric disorders. Although not statistically significant, patients with schizophrenia were less likely to undergo cancer-directed surgery. CONCLUSIONS: Patients with pancreatic cancer and comorbid schizophrenia were significantly more likely to present with advanced cancer at admission, were less likely to receive chemotherapy, had longer hospital stays, and experienced higher 30-day in-hospital mortality than those without psychiatric disorders. Although not statistically significant, patients with schizophrenia were less likely to undergo cancer-directed surgery.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Lin J, Sato S, Aso S, et al. Association of comorbid schizophrenia with cancer stage at admission, treatments, length of stay, and 30-day in-hospital mortality in patients with pancreatic cancer: A retrospective matched-pair cohort study in Japan. Eur J Cancer. 2025. PMID: 40311505. doi:10.1016/j.ejca.2025.115468

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。